The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?

While the world is facing the urgency of the COVID-19 pandemic, policymakers must plan for the direct response to the outbreak while minimising its collateral impact. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerin, Philippe J, Singh-Phulgenda, Sauman, Strub-Wourgaft, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Opinion Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284150/
https://www.ncbi.nlm.nih.gov/pubmed/32566139
http://dx.doi.org/10.12688/f1000research.23057.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284150/
https://www.ncbi.nlm.nih.gov/pubmed/32566139
http://dx.doi.org/10.12688/f1000research.23057.1

Ejemplares similares